Skip to main content
Fig. 6 | Acta Neuropathologica Communications

Fig. 6

From: Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients

Fig. 6

Scatterplots of DEPs which were differential between sCAA patients and control subjects. A Secretogranins 1, 2, and 3 all were significantly decreased in sCAA patients compared to control subjects. B Serpins A3 (anti-chymotrypsin), C1 (antithrombin), and I1 (neuroserpin) were significantly increased (SERPINA3, C1) or decreased (SERPINI1) in sCAA patients vs. control subjects. ***p < 0.001. **p < 0.01, *p < 0.05

Back to article page